Diabetes and Obesity

作者: Behzad Salari , Shabnam Samankan , Jahan Porhomayon

DOI: 10.1016/B978-0-12-800093-9.00002-8

关键词:

摘要: An increasing rate of type 2 diabetes (T2D) and obesity imposes a huge financial drain on healthcare systems. Diabesity describes their close pathophysiological clinical associations. Both are associated with an increased risk cardiovascular renal diseases. Multiple factors including biochemical, metabolic, genetic, cultural, psychosocial conditions contribute to insulin resistance. The coexistence T2D presents complex therapeutic management challenge remains undertreated in primary care. Lifestyle modifications remain the cornerstone such management. Medical treatment strategies for diabesity should be multifactorial, addressing its multiple metabolic abnormalities. Selection appropriate agents therefore becomes challenging, long-term monitoring is essential. There need newer anti-diabetic medications more effective weight-lowering properties. It hoped that scientific information derived from metabolite-profiling techniques will make it possible suggest individualized this chronic condition.

参考文章(63)
S. B. Russo, J. S. Ross, L. A. Cowart, Sphingolipids in obesity, type 2 diabetes, and metabolic disease. Handbook of experimental pharmacology. pp. 373- 401 ,(2013) , 10.1007/978-3-7091-1511-4_19
C. D. A. Stehouwer, M. M. J. van Greevenbroek, C. G. Schalkwijk, Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences Netherlands Journal of Medicine. ,vol. 71, pp. 174- 187 ,(2013)
M. R. Meyer, D. J. Clegg, E. R. Prossnitz, M. Barton, Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors Acta Physiologica. ,vol. 203, pp. 259- 269 ,(2011) , 10.1111/J.1748-1716.2010.02237.X
Graham A Colditz, Walter C Willett, Andrea Rotnitzky, JoAnn E Manson, Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women Annals of Internal Medicine. ,vol. 122, pp. 481- 486 ,(1995) , 10.7326/0003-4819-122-7-199504010-00001
Hannah Gardener, Tatjana Rundek, Matthew Markert, Clinton B Wright, Mitchell SV Elkind, Ralph L Sacco, None, Diet Soft Drink Consumption is Associated with an Increased Risk of Vascular Events in the Northern Manhattan Study Journal of General Internal Medicine. ,vol. 27, pp. 1120- 1126 ,(2012) , 10.1007/S11606-011-1968-2
Joan Vendrell, Matilde R. Chacón, TWEAK: a new player in obesity and diabetes Frontiers in Immunology. ,vol. 4, pp. 488- 488 ,(2013) , 10.3389/FIMMU.2013.00488
Enzo Nisoli, Emilio Clementi, Michele O. Carruba, Salvador Moncada, Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome? Circulation Research. ,vol. 100, pp. 795- 806 ,(2007) , 10.1161/01.RES.0000259591.97107.6C
L.M. Brown, D.J. Clegg, Central effects of estradiol in the regulation of food intake, body weight, and adiposity The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 122, pp. 65- 73 ,(2010) , 10.1016/J.JSBMB.2009.12.005
Yu-Hung Chang, Dao-Ming Chang, Kun-Cheng Lin, Shyi-Jang Shin, Yau-Jiunn Lee, Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review Diabetes-metabolism Research and Reviews. ,vol. 27, pp. 515- 527 ,(2011) , 10.1002/DMRR.1201